Immuno - Oncoloy: A New Class Of Drugs

AUA2024: Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice CME Available: https://auau.auanet.org/node/40976 At the conclusion of...

26 Kesä 20242h 4min

AUA2024: Management of Non-Muscle Invasive Bladder Cancer: Practical Solutions for Common Problems CME Available: https://auau.auanet.org/node/41097 At the conclusion of this activity, participants ...

19 Kesä 20241h 52min

AUA2024: Contemporary Pharmacotherapy for OAB 2024: Monotherapy and Combined Pharmacotherapy to Optimize Treatment CME Available: https://auau.auanet.org/node/41048 At the conclusion of this activit...

12 Kesä 20242h 6min

AUA2024: AUA Advanced Prostate Cancer Guidelines CME Available: https://auau.auanet.org/node/41027 At the conclusion of this activity, participants will be able to: 1. Identify appropriate use of g...

5 Kesä 20242h 5min

Live from AUA2024: Highlights in Bladder Cancer CME Available: https://auau.auanet.org/node/41085 At the conclusion of this activity, participants will be able to: 1. Discuss the newly released amen...

31 Touko 202452min

AUA2024: Upper Tract Urothelial Carcinoma Tumor Board: A Case-Based Approach to Management CME Available: https://auau.auanet.org/node/41040 At the conclusion of this activity, participants will be...

29 Touko 20241h 54min

AUA2024: Chemotherapy and Immunotherapy for the Urologist and Advanced Practice Provider CME Available: https://auau.auanet.org/node/41015 At the conclusion of this activity, participants will be ab...

22 Touko 20241h 56min

Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder (OAB) Webcast (2024) CME Available: https://auau.auanet.org/node/41056 At the conclusion of this activity, particip...

15 Touko 20241h 56min